Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intramuscular spectinomycin for refractory Mycoplasma genitalium infection
jRCT1051250053Not yet recruiting
- Sponsor
- Osaka Umeda Shinshi Clinic
- Start
- Jun 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of spectinomycin in Mycoplasma genitalium infection (Mgen), sponsored by Osaka Umeda Shinshi Clinic. Primary endpoint: MG/TVPCR. Planned start Jun 2025; status: not yet recruiting.
02
Drugs
spectinomycin
03
Conditions
Mycoplasma genitalium infection (Mgen)
Beyond the preview
Go deeper on jRCT1051250053.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1051250053.